
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Expanding Chemical Probe Space: Quality Criteria for Covalent and Degrader Probes
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 56
Ingo V. Hartung, Joachim Rudolph, Mary M. Mader, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 14, pp. 9297-9312
Open Access | Times Cited: 56
Showing 1-25 of 56 citing articles:
Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 46
Laura Hillebrand, Xiaojun Julia Liang, Ricardo Augusto Massarico Serafim, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 10, pp. 7668-7758
Closed Access | Times Cited: 46
DCAF1-based PROTACs with activity against clinically validated targets overcoming intrinsic- and acquired-degrader resistance
Martin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Martin Schröder, Martin Renatus, Xiaoyou Liang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 37
Chemoproteomics Identifies State-Dependent and Proteoform-Selective Caspase-2 Inhibitors
José O. Castellón, Samuel Ofori, Nikolas R. Burton, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 22, pp. 14972-14988
Closed Access | Times Cited: 15
José O. Castellón, Samuel Ofori, Nikolas R. Burton, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 22, pp. 14972-14988
Closed Access | Times Cited: 15
Functional Characterization of Pathway Inhibitors for the Ubiquitin-Proteasome System (UPS) as Tool Compounds for CRBN and VHL-Mediated Targeted Protein Degradation
Martin P. Schwalm, Amelie Menge, Lewis Elson, et al.
ACS Chemical Biology (2025) Vol. 20, Iss. 1, pp. 94-104
Open Access | Times Cited: 2
Martin P. Schwalm, Amelie Menge, Lewis Elson, et al.
ACS Chemical Biology (2025) Vol. 20, Iss. 1, pp. 94-104
Open Access | Times Cited: 2
Chemical Proteomic Discovery of Isotype‐Selective Covalent Inhibitors of the RNA Methyltransferase NSUN2
Yongfeng Tao, Jan G. Felber, Zhongyu Zou, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 51
Open Access | Times Cited: 26
Yongfeng Tao, Jan G. Felber, Zhongyu Zou, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 51
Open Access | Times Cited: 26
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6549-6569
Closed Access | Times Cited: 8
Moritz Schwarz, Maksym Kurkunov, Florian Wittlinger, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 8, pp. 6549-6569
Closed Access | Times Cited: 8
Expanding the ligand spaces for E3 ligases for the design of protein degraders
Rahman Shah Zaib Saleem, Martin P. Schwalm, Stefan Knapp
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117718-117718
Open Access | Times Cited: 8
Rahman Shah Zaib Saleem, Martin P. Schwalm, Stefan Knapp
Bioorganic & Medicinal Chemistry (2024) Vol. 105, pp. 117718-117718
Open Access | Times Cited: 8
Chemical tools to expand the ligandable proteome: diversity-oriented synthesis-based photoreactive stereoprobes
Daisuke Ogasawara, David B. Konrad, Zher Yin Tan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Daisuke Ogasawara, David B. Konrad, Zher Yin Tan, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
Identification of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Closed Access | Times Cited: 7
Eric M. Merten, John D. Sears, Tina M. Leisner, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 42
Closed Access | Times Cited: 7
Delineating cysteine-reactive compound modulation of cellular proteostasis processes
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
Nature Chemical Biology (2024)
Closed Access | Times Cited: 7
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
Nature Chemical Biology (2024)
Closed Access | Times Cited: 7
Covalent hits and where to find them
Simon C. C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100142-100142
Open Access | Times Cited: 6
Simon C. C. Lucas, J. Henry Blackwell, Sarah H. Hewitt, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 3, pp. 100142-100142
Open Access | Times Cited: 6
Covalent Degrader of the Oncogenic Transcription Factor β-Catenin
Flor A. Gowans, Nafsika Forte, J. D. Hatcher, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 24, pp. 16856-16865
Open Access | Times Cited: 6
Flor A. Gowans, Nafsika Forte, J. D. Hatcher, et al.
Journal of the American Chemical Society (2024) Vol. 146, Iss. 24, pp. 16856-16865
Open Access | Times Cited: 6
Targeting TAK1: Evolution of inhibitors, challenges, and future directions
Nika Strašek Benedik, Matic Proj, Christian Steinebach, et al.
Pharmacology & Therapeutics (2025) Vol. 267, pp. 108810-108810
Open Access
Nika Strašek Benedik, Matic Proj, Christian Steinebach, et al.
Pharmacology & Therapeutics (2025) Vol. 267, pp. 108810-108810
Open Access
PK/PD modeling of targeted protein degraders: Charting new waters and navigating the shallows
Robin Thomas Ulrich Haid, Andreas Reichel
Drug Discovery Today (2025), pp. 104311-104311
Open Access
Robin Thomas Ulrich Haid, Andreas Reichel
Drug Discovery Today (2025), pp. 104311-104311
Open Access
Selective and Potent Molecular Glue Degraders for NIMA‐related Kinase 7
Lu Chen, Lu Huang, Wuqiang Wen, et al.
Angewandte Chemie (2025)
Closed Access
Lu Chen, Lu Huang, Wuqiang Wen, et al.
Angewandte Chemie (2025)
Closed Access
Workflow for E3 Ligase Ligand Validation for PROTAC Development
Nebojša Miletić, Janik Weckesser, Thorsten Mosler, et al.
ACS Chemical Biology (2025)
Open Access
Nebojša Miletić, Janik Weckesser, Thorsten Mosler, et al.
ACS Chemical Biology (2025)
Open Access
Comparative Evaluation and Profiling of Chemical Tools for the Nuclear Hormone Receptor Family 2
Max Lewandowski, Romy Busch, Julian A. Marschner, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Max Lewandowski, Romy Busch, Julian A. Marschner, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells
Mélanie Uguen, Devan J. Shell, Madhushika Silva, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Mélanie Uguen, Devan J. Shell, Madhushika Silva, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Probing cancer with small-molecule tools—Progress and challenges
Susanne Müller, Domenico Sanfelice, Paul Workman
Cancer Cell (2025)
Closed Access
Susanne Müller, Domenico Sanfelice, Paul Workman
Cancer Cell (2025)
Closed Access
A covalent chemical probe for Chikungunya nsP2 cysteine protease with antialphaviral activity and proteome-wide selectivity
Anirban Ghoshal, Edwin G. Tse, Mohammad Anwar Hossain, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Anirban Ghoshal, Edwin G. Tse, Mohammad Anwar Hossain, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Recommended Tool Compounds: Thienotriazolodiazepines-Derivatized Chemical Probes to Target BET Bromodomains
Chuhui Huang, Claire L. Harris, Ghizal Siddiqui, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Chuhui Huang, Claire L. Harris, Ghizal Siddiqui, et al.
ACS Pharmacology & Translational Science (2025)
Closed Access
Degron tagging for rapid protein degradation in mice
Brianda Areli Hernández-Morán, Gillian C.A. Taylor, Álvaro Lorente‐Macías, et al.
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 4
Brianda Areli Hernández-Morán, Gillian C.A. Taylor, Álvaro Lorente‐Macías, et al.
Disease Models & Mechanisms (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 4
Chemical tools to expand the ligandable proteome: Diversity-oriented synthesis-based photoreactive stereoprobes
Daisuke Ogasawara, David B. Konrad, Zher Yin Tan, et al.
Cell chemical biology (2024)
Open Access | Times Cited: 4
Daisuke Ogasawara, David B. Konrad, Zher Yin Tan, et al.
Cell chemical biology (2024)
Open Access | Times Cited: 4
Pervasive aggregation and depletion of host and viral proteins in response to cysteine-reactive electrophilic compounds
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10
Ashley R. Julio, Flowreen Shikwana, Cindy Truong, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 10